• Neuromedin U: A Candidate Biomarker and Therapeutic Target to Predict and Overcome Resistance to HER-Tyrosine Kinase Inhibitors.

    Thumbnail Image

    Files

    Cancer Res-2014-Rani-3821-33.pdf (2.38 MB)

    Date

    2014

    Authors

    Journal Title

    Journal ISSN

    Volume Title

    Publisher

    Access

    openAccess

    Embargo end date

    Citation

    Rani S, Corcoran C, Shiels L, Germano S, Breslin S, Madden S, McDermott MS, Browne BC, O'Donovan N, Crown J, Gogarty M, Byrne AT, O'Driscoll L, Neuromedin U: A Candidate Biomarker and Therapeutic Target to Predict and Overcome Resistance to HER-Tyrosine Kinase Inhibitors., Cancer Research, 74, 14, 2014, 3821 - 3833

    Abstract

    Description

    PUBLISHED

    URI

    http://hdl.handle.net/2262/75496

    Collections

    Pharmacy and Pharmaceutical Sciences (Scholarly Publications)
    RSS Feeds

    Endorsement

    Review

    Supplemented By

    Referenced By

    Keywords

    Author's Homepage: http://people.tcd.ie/lodrisc

    Author: O'Driscoll, Lorraine

    Type of material: Journal Article